These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 18456460

  • 1. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis.
    Wood SJ, Berger GE, Wellard RM, Proffitt T, McConchie M, Velakoulis D, McGorry PD, Pantelis C.
    Schizophr Res; 2008 Jul; 102(1-3):163-70. PubMed ID: 18456460
    [Abstract] [Full Text] [Related]

  • 2. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.
    Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
    Plitman E, de la Fuente-Sandoval C, Reyes-Madrigal F, Chavez S, Gómez-Cruz G, León-Ortiz P, Graff-Guerrero A.
    Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
    [Abstract] [Full Text] [Related]

  • 8. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF.
    Psychiatry Res; 2003 Jun 30; 123(2):87-100. PubMed ID: 12850248
    [Abstract] [Full Text] [Related]

  • 9. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A.
    Pharmacopsychiatry; 2005 Sep 30; 38(5):214-9. PubMed ID: 16189748
    [Abstract] [Full Text] [Related]

  • 10. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H, Fukui T, Fukuda R, Kasai K, Iwanami A, Kato N, Kato T.
    Int J Neuropsychopharmacol; 2003 Dec 30; 6(4):353-60. PubMed ID: 14604450
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 30; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A.
    Psychiatr Pol; 2003 Dec 30; 37(6):977-88. PubMed ID: 14727370
    [Abstract] [Full Text] [Related]

  • 14. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.
    Arch Gen Psychiatry; 2006 Feb 30; 63(2):139-49. PubMed ID: 16461856
    [Abstract] [Full Text] [Related]

  • 15. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.
    Psychiatry Clin Neurosci; 2006 Jun 30; 60(3):365-72. PubMed ID: 16732755
    [Abstract] [Full Text] [Related]

  • 16. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
    Galińska-Skok B, Małus A, Konarzewska B, Rogowska-Zach A, Milewski R, Tarasów E, Szulc A, Waszkiewicz N.
    Dis Markers; 2018 Jun 30; 2018():3654894. PubMed ID: 30595760
    [Abstract] [Full Text] [Related]

  • 17. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
    Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Nakataki M, Ueno S, Harada M, Ohmori T.
    Schizophr Res; 2009 Mar 30; 108(1-3):69-77. PubMed ID: 19097753
    [Abstract] [Full Text] [Related]

  • 18. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.
    Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.